Argentina Pharmaceuticals and Healthcare Report Q3 2014

  • June 2014
  • -
  • Business Monitor International
  • -
  • 128 pages

Includes 3 FREE quarterly updates
BMI View: Argentina's unpredictable and highly interventionist style of government practices will not be
able to amend the country's economic concerns or resolve issues in the pharmaceutical industry. The local
pharmaceutical market and healthcare system will continue to deteriorate due to insufficient medicine
supply. Domestic inflation in Argentina will continue to erode the competitiveness of its pharmaceutical
exports, minimising gains from a weaker spot exchange rate. Trade relationships are already significantly
distorted due to frequent government policy interventions..




Headline Expenditure Projections


Pharmaceuticals: ARS39.30bn (USD7.18 bn) in 2013 to ARS50.51bn (USD6.09bn) in 2014; +28.5% in
local currency terms and -15.2% in US dollar terms. These figures have been revised downwards since
Q214 due to a substantial deterioration in high frequency economic data.

Table Of Contents

Argentina Pharmaceuticals and Healthcare Report Q3 2014
BMI Industry View ... 7
SWOT 9
Political . 11
Economic ... 12
Business Environment .. 13
Industry Forecast .. 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Argentina 2010-2018) . 16
Healthcare Expenditure Forecast ... 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2010-2018) . . 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2010-2018) 18
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Argentina 2010-2018) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Argentina 2010-2018) . . 21
Patented Drug Market Forecast . 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Argentina 2010-2018) 23
Generic Drug Market Forecast .. 24
Table: Generics Drug Market Indicators, Historical Data And Forecasts . 25
OTC Medicine Market Forecast . 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Argentina 2010-2018) . . 27
Pharmaceutical Trade Forecast . 28
Table: Pharmaceutical Trade Data And Forecasts . 29
Table: Pharmaceutical Trade Data And Forecasts ARSmn . . 30
Other Healthcare Forecasts ... 31
Key Risks To BMI's Forecast Scenario . 31
Macroeconomic Forecasts ... 33
Table: Argentina - GDP By Expenditure . . 38
Industry Risk Reward Ratings .. 39
Americas Risk/Reward Ratings ... 39
Argentina Risk/Reward Ratings .. 45
Rewards ... 45
Risks 46
Market Overview ... 47
Industry Trends And Developments 48
Epidemiology 48
Healthcare 49
Healthcare Insurance .. 50
Medical Tourism 51
Research and Development 52
Table: Pharmaceutical RandD Investment, 2001-2007 . . 53
Clinical Trials ... 55
Regulatory Development .. 57
Table: Product Registration, Annex I and II Listed Countries 58
Intellectual Property Environment . 63
Pricing and Reimbursement 70
Table: Pharmaceutical Price Build-Up . 71
Table: Taxes Paid by the Pharmaceutical Industry by Type, 2005-2007 (ARSmn) . . 72
Table: Drug Price Freeze, 2005-2008 . . 73
Reimbursement Regime ... 73
Other Regulatory Issues .. 74
Competitive Landscape 76
Domestic Pharmaceutical Sector ... 77
Foreign Pharmaceutical Sector 80
Recent Company Developments 82
Pharmaceutical Wholesale Sector . 85
Retail Pharmacy Sector ... 86
Company Profile 90
Roemmers .. 90
Laboratorios Bago ... 94
Novartis . 98
Boehringer Ingelheim . 101
Merck and Co .. 103
GlaxoSmithKline ... 106
Roche .. 109
Sanofi .. 112
Pfizer .. 115
Demographic Forecast ... 118
Demographic Outlook 118
Table: Argentina's Population By Age Group, 1990-2020 ('000) . 119
Table: Argentina's Population By Age Group, 1990-2020 (% of total) . 120
Table: Argentina's Key Population Ratios, 1990-2020 . . 121
Table: Argentina's Urban And Rural Population, 1990-2020 . . 121
Glossary ... 122
Methodology 124
Pharmaceutical Expenditure Forecast Model 124
Healthcare Expenditure Forecast Model ... 124
Notes On Methodology .. 125
Risk/Reward Ratings Methodology .. 126
Ratings Overview . 127
Table: Pharmaceutical Risk/Reward Ratings Indicators . 127
Indicator Weightings 128

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023

  • $ 10 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - Global Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with ...

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023

  • $ 6 995
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Irritable Bowel Syndrome - 5EU Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered ...

New Technologies that will Impact the Global Pharmaceutical Packaging Industry : Customisation is the New Formula

New Technologies that will Impact the Global Pharmaceutical Packaging Industry : Customisation is the New Formula

  • $ 6 000
  • Industry report
  • December 2014
  • by Frost & Sullivan

Key Questions This Study Will Answer How big is the pharmaceutical packaging industry? Which are the key factors driving the industry and what are the restraints hampering its growth? Who are the news ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.